Abstract
Both enveloped and non-enveloped viruses from different families may use heparan sulfates (HS) to bind to and / or enter into their host cells. The interactions between viruses and HS can be inhibited by a novel class of antiviral compounds, the N,N-bisheteryl derivatives of 3,12-diaza-6,9-diazoniadispiro(5,2,5,2) hexadecane which bind to specific structural moieties of HS. By this way these compounds block adsorption of viruses that use HS as their initial interaction site with the cell, e.g. herpes simplex viruses, cytomegalovirus, respiratory syncytial virus, and human immunodeficiency viruses.
Keywords: receptor, heparan sulfate, proteoglycans, dispirotripiperazine, virus, antiviral
Letters in Drug Design & Discovery
Title: Novel Opportunities to Study and Block Interactions between Viruses and Cell Surface Heparan Sulfates by using Dispirotripiperazines
Volume: 1 Issue: 4
Author(s): M. Schmidtke, P. Wutzler and V. Makarov
Affiliation:
Keywords: receptor, heparan sulfate, proteoglycans, dispirotripiperazine, virus, antiviral
Abstract: Both enveloped and non-enveloped viruses from different families may use heparan sulfates (HS) to bind to and / or enter into their host cells. The interactions between viruses and HS can be inhibited by a novel class of antiviral compounds, the N,N-bisheteryl derivatives of 3,12-diaza-6,9-diazoniadispiro(5,2,5,2) hexadecane which bind to specific structural moieties of HS. By this way these compounds block adsorption of viruses that use HS as their initial interaction site with the cell, e.g. herpes simplex viruses, cytomegalovirus, respiratory syncytial virus, and human immunodeficiency viruses.
Export Options
About this article
Cite this article as:
Schmidtke M., Wutzler P. and Makarov V., Novel Opportunities to Study and Block Interactions between Viruses and Cell Surface Heparan Sulfates by using Dispirotripiperazines, Letters in Drug Design & Discovery 2004; 1 (4) . https://dx.doi.org/10.2174/1570180043398768
DOI https://dx.doi.org/10.2174/1570180043398768 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology Immune Restoration Disease: A Consequence of Dysregulated Immune Responses After HAART
Current HIV Research Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design Bacteriophage - A Common Divergent Therapeutic Approach for Alzheimer's Disease and Type II Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Identification of Pyrazole Derivative as an Antiviral Agent Against Chikungunya Through HTVS
Letters in Drug Design & Discovery Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Recent Patents on Anti-Cancer Drug Discovery Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Current Neuropharmacology Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis
Current Signal Transduction Therapy Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy ATP-Binding Cassette Transporters in Inflammatory Brain Disease
Current Pharmaceutical Design Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle
CNS & Neurological Disorders - Drug Targets Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
Central Nervous System Agents in Medicinal Chemistry Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets A Concise Review on Multidimensional Silver Nanoparticle Health Aids and Threats
Current Drug Therapy Therapeutic Options for the Treatment of 2019-Novel Coronavirus in India: A Review
Coronaviruses Animal Models Used for the Evaluation of Antiretroviral Therapies
Current HIV Research